Cellectar Biosciences Announces Successful Completion of $7.76 Million Registered Direct Offering

World News: . []

MADISON Wis Oct 12 2017 GLOBE NEWSWIRE -- Cellectar Biosciences Inc Nasdaq CLRB Cellectar or the Company an oncology-focused biotechnology company, today announces the closing of its registered direct offering priced at-the-mar ket, of...

More news and information about Cellectar Biosciences, Inc.

Published By:

Globe Newswire: 16:00 GMT Thursday 12th October 2017

Published: .

Search for other references to "cellectar" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us